CollPlant Biotechnologies (CLGN) Amortization of Deferred Charges (2020 - 2024)

CollPlant Biotechnologies (CLGN) has 5 years of Amortization of Deferred Charges data on file, last reported at $173000.0 in Q3 2024.

• Quarterly Amortization of Deferred Charges rose 30.08% year-over-year to $173000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $560000.0 (down 33.96% YoY) and the FY2022 annual result came in at $461000.0, up 15.25% from the prior year.
• Amortization of Deferred Charges climbed to $173000.0 in Q3 2024, from $133000.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $461000.0 in Q4 2022 to a low of $50000.0 in Q1 2020.
• A 5-year average of $139692.3 and a median of $112000.0 in 2021 frame the typical range for Amortization of Deferred Charges.
• Annual changes were most pronounced in 2022 — Amortization of Deferred Charges jumped 311.61% — and 2023, when it climbed 6.4%.
• Tracing CLGN's Amortization of Deferred Charges over 5 years: stood at $50000.0 in 2020, then soared by 124.0% to $112000.0 in 2021, then jumped by 311.61% to $461000.0 in 2022, then tumbled by 71.15% to $133000.0 in 2023, then surged by 30.08% to $173000.0 in 2024.
• The last three Amortization of Deferred Charges figures came in at $173000.0 (Q3 2024), $133000.0 (Q3 2023), and $135000.0 (Q2 2023), per Business Quant data.